Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Blood Cancer
Recent news which mentions Blood Cancer
AstraZeneca Says Calquence/Chemo Combo Data Shows Additional 16.8 Months Without Disease Progression In Patients With Certain Type Of Blood Cancer
June 17, 2024
Tickers
AZN
NEWS
Tags
Market News
Benzinga
Biotech
From
Benzinga
House Majority Leader Steve Scalise Diagnosed With Treatable Blood Cancer
August 30, 2023
Tickers
GOP
Tags
Politics
Steve Scalise
Benzinga
From
Benzinga
Five clinical trials impacting blood cancers approved for funding
August 08, 2023
Tags
Clinical Trials
Pediatrics
Biotech
From
PRLog
Overcoming Blood Cancer With CAR T-cell Therapy: Eleonora's Journey
September 07, 2022
Tags
non/Hodgkin lymphoma
Health & Healthcare
CAR T/cell Therapy
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Gilead Withdraws Use Of Zydelig In Two Forms Of Blood Cancer In US
January 18, 2022
Tickers
GILD
Tags
Briefs
FDA
GILD
From
Benzinga
IDI Consulting Supports the Leukemia & Lymphoma Society's Light The Night Walk
October 25, 2021
Tags
Philanthropy
Blood Cancer
Event
From
PRLog
Takeda's Breakthrough Blood Cancer Drug Flunks In Phase 3 Study
September 02, 2021
Tickers
TAK
TKPHF
Tags
FDA
TAK
Benzinga
From
Benzinga
Pfizer Beefs Up Blood Cancer Pipeline With Trillium Acquisition: See Highlights
August 23, 2021
Tickers
PFE
TRIL
Tags
Long Ideas
Benzinga
Market News
From
Benzinga
BeiGene's Brukinsa Prolongs Progression-Free Survival Compared To Chemo In Untreated Blood Cancer Patients
July 30, 2021
Tickers
BGNE
Tags
Biotech
blood cancer
News
From
Benzinga
Magenta Therapeutics Stock Drops As FDA Issues Clinical Hold On Blood Cancer Candidate IND
July 21, 2021
Tickers
MGTA
Tags
MGTA
General
Biotech
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.